High serum miR-223-3p expression level predicts complete response and prolonged overall survival in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation

INTRODUCTION: AHSCT is the treatment of choice for newly diagnosed patients with transplant-eligible multiple myeloma (MM). However, considerable variability in response to autologous hematopoietic stem cell transplantation (AHSCT) results in only 50% of patients achieving complete response (CR) aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikulski, Damian, Nowicki, Mateusz, Dróźdż, Izabela, Misiewicz, Małgorzata, Kościelny, Kacper Piotr, Okoński, Karol, Krawiec, Kinga, Perdas, Ewelina, Wierzbowska, Agnieszka, Fendler, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565214/
https://www.ncbi.nlm.nih.gov/pubmed/37829335
http://dx.doi.org/10.3389/fonc.2023.1250355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565214/
https://www.ncbi.nlm.nih.gov/pubmed/37829335
http://dx.doi.org/10.3389/fonc.2023.1250355

Ejemplares similares